Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2017, 63, 202-208

https://doi.org/10.14712/fb2017063050202

Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression

Grzegorz Szparecki, T. Ilczuk, N. Gabzdyl, B. Górnicka

Department of Pathology, Medical University of Warsaw, Warsaw, Poland

Received November 2017
Accepted February 2018

References

1. Agrawal, S., Agarwal, S., Arnason, T., Saini, S., Belghiti, J. (2015) Management of hepatocellular adenoma: recent advances. Clin. Gastroenterol. Hepatol. 13, 1221-1230. <https://doi.org/10.1016/j.cgh.2014.05.023>
2. Augello, G., Puleio, R., Emma, M. R., Cusimano, A., Loria, G. R., McCubrey, J. A., Montalto, G., Cervello, M. (2016) A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells. Cell Cycle 15, 573-583. <https://doi.org/10.1080/15384101.2016.1138183>
3. Bendib, M., Badescu, A., Handra-Luca, A. (2015) PTEN expression in colorectal adenomas: relationship to morphology and cell heterogeneity. Pathol. Res. Pract. 211, 248-251. <https://doi.org/10.1016/j.prp.2014.12.007>
4. Calderaro, J., Nault, J. C., Balabaud, C., Couchy, G., Saint- Paul, M. C., Azoulay, D., Mehdaoui, D., Luciani, A., Zafrani, E. S., Bioulac-Sage, P., Zucman-Rossi, J. (2016) Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Mod. Pathol. 29, 43-50. <https://doi.org/10.1038/modpathol.2015.119>
5. Choi, W. T., Ramachandran, R., Kakar, S. (2017) Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum. Pathol. 63, 1-13. <https://doi.org/10.1016/j.humpath.2016.12.025>
6. Chu, E. C., Tarnawski, A. S. (2004) PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. 10, RA235-241.
7. Davies, E. J., Marsh Durban, V., Meniel, V., Williams, G. T., Clarke, A. R. (2014) PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine. J. Pathol. 233, 27-38. <https://doi.org/10.1002/path.4312>
8. Dominguez-Malagon, H., Gaytan-Graham, S. (2001) Hepatocellular carcinoma: an update. Ultrastruct. Pathol. 25, 497-516. <https://doi.org/10.1080/019131201753343539>
9. Hu, T. H., Huang, C. C., Lin, P. R., Chang, H. W., Ger, L. P., Lin, Y. W., Changchien, C. S., Lee, C. M., Tai, M. H. (2003) Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97, 1929-1940. <https://doi.org/10.1002/cncr.11266>
10. Leslie, N. R., Downes, C. P. (2004) PTEN function: how normal cells control it and tumour cells lose it. Biochem. J. 382, 1-11. <https://doi.org/10.1042/BJ20040825>
11. Liu, T. C., Vachharajani, N., Chapman, W. C., Brunt, E. M. (2014) Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod. Pathol. 27, 420-432. <https://doi.org/10.1038/modpathol.2013.148>
12. Lloyd, K. M., 2nd, Dennis, M. (1963) Cowden’s disease. A possible new symptom complex with multiple system involvement. Ann. Intern. Med. 58, 136-142. <https://doi.org/10.7326/0003-4819-58-1-136>
13. Lu, Z., Guo, H., Lin, Y., Shen, L., Yin, C., Xie, S. (2017) Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells. J. Oral. Pathol. Med. 46, 31-38. <https://doi.org/10.1111/jop.12461>
14. Lynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P. M., Kvinnsland, S., Gjertsen, B. T., Heimdal, K., Lubs, H., Moller, P., King, M. C. (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet. 61, 1254-1260. <https://doi.org/10.1086/301639>
15. Marsh, V., Winton, D. J., Williams, G. T., Dubois, N., Trumpp, A., Sansom, O. J., Clarke, A. R. (2008) Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat. Genet. 40, 1436-1444. <https://doi.org/10.1038/ng.256>
16. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., Patel, T. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658. <https://doi.org/10.1053/j.gastro.2007.05.022>
17. Molinari, F., Frattini, M. (2013) Functions and regulation of the PTEN gene in colorectal cancer. Front. Oncol. 3, 326.
18. Pap, Z., Ilyes, I. A., Mocan, S. L., Denes, L., Muica Nagy- Bota, M. C., Pavai, Z., Szanto, A. (2015) Changes in immunoexpression of p53, Ki-67, Ets-1, APAF-1 and PTEN in serrated and conventional colon adenomas. Rom. J. Morphol. Embryol. 56, 1389-1396.
19. Roncalli, M., Sciarra, A., Tommaso, L. D. (2016) Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin. Mol. Hepatol. 22, 199-211. <https://doi.org/10.3350/cmh.2016.0101>
20. Schlageter, M., Terracciano, L. M., D’Angelo, S., Sorrentino, P. (2014) Histopathology of hepatocellular carcinoma. World J. Gastroenterol. 20, 15955-15964. <https://doi.org/10.3748/wjg.v20.i43.15955>
21. Shafizadeh, N., Kakar, S. (2011) Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv. Anat. Pathol. 18, 438-445. <https://doi.org/10.1097/PAP.0b013e318234abb4>
22. Siddiqui, S., Akhter, N., Deo, S. V., Shukla, N. K., Husain, S. A. (2016) A study on promoter methylation of PTEN in sporadic breast cancer patients from North India. Breast Cancer 23, 922-931. <https://doi.org/10.1007/s12282-015-0665-0>
23. Tekcham, D. S., Gupta, S., Shrivastav, B. R., Tiwari, P. K. (2017) Epigenetic downregulation of PTEN in gallbladder cancer. J. Gastrointest. Cancer 48, 110-116. <https://doi.org/10.1007/s12029-017-9919-8>
24. Unseld, M., Chilla, A., Pausz, C., Mawas, R., Breuss, J., Zielinski, C., Schabbauer, G., Prager, G. W. (2015) PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis. Thromb. Haemost. 114, 379-389. <https://doi.org/10.1160/TH15-01-0016>
25. Xi, Y., Chen, Y. (2017) PTEN plays dual roles as a tumor suppressor in osteosarcoma cells. J. Cell. Biochem. 118, 2684-2692. <https://doi.org/10.1002/jcb.25888>
26. Yan, T., Jiang, X., Guo, X., Chen, W., Tang, D., Zhang, J., Zhang, X., Zhang, D., Zhang, Q., Jia, J., Huang, Y. (2017) Electric field-induced suppression of PTEN drives epithelial- to-mesenchymal transition via mTORC1 activation. J. Dermatol Sci, 85, 96-105. <https://doi.org/10.1016/j.jdermsci.2016.11.007>
27. Ye, Z. L., Huang, Y., Li, L. F., Zhu, H. L., Gao, H. X., Liu, H., Lv, S. Q., Xu, Z. H., Zheng, L. N., Liu, T., Zhang, J. L., Jin, H. J., Qian, Q. J. (2015) Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacol. Sin. 36, 1237-1245. <https://doi.org/10.1038/aps.2015.18>
28. Zhang, D., Zhou, P., Wang, W., Wang, X., Li, J., Sun, X., Zhang, L. (2016) MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN. Oncol. Rep. 35, 366-374. <https://doi.org/10.3892/or.2015.4334>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive